Ugro Capital’s record is clean on its face: unqualified audit opinions across seven years and operating cash flow that now covers reported profit. Three things deserve attention: the promoter MD’s remuneration terms embed a five-year guaranteed payout on change-in-control against near-zero promoter equity, the company has appointed G.P. Kapadia & Co. as statutory auditors for FY2026-27, and off-book assets have grown to 38% of the loan book while on-book debt has risen sixfold to ₹10,782 crore.
Key findings
- Promoter MD’s variable compensation resolution failed, while re-appointment passed
Major- Mr. Shachindra Nath’s re-appointment as Vice Chairman and Managing Director was approved at the 29 May 2026 AGM with 44.00% votes against, while public institutions voted 74.75% against. The special resolution to approve his variable compensation failed at the same AGM with 44.01% votes against. His terms include a company-funded bank guarantee covering losses from his personal guarantees, an automatic deferred-compensation escalator, and a payout equal to five years of total pay upon a change in control, all set against promoter equity of just 2.88%. - Off-book AUM has grown to 38% of total AUM, while consolidated debt has risen sixfold
Major- Off-book AUM rose from 16% of total AUM in March 2022 to 38% in March 2026, while consolidated debt grew from ₹1,821 crore to ₹10,782 crore over the same period. Borrowings guaranteed by a director stood at ₹1,829.74 crore as at 31 March 2026, and two covenant breaches occurred in FY2024-25, CRAR fell to 19.41% against a 20% requirement on public NCDs, and repossessed stock exceeded a ₹200 crore ceiling. Interest coverage stood at 1.26x as at 31 March 2026. - Revenue quality is pressured by volatile co-lending income and upfront derecognition gains
Minor- Management stated in Q4 FY26 that co-lending income is “very severe and high” in volatility and does not accrete to capital adequacy net worth until realised. Gains from de-recognition transactions are recorded upfront in the profit and loss account, while credit cost rose from ₹56.8 crore in FY23 to ₹116.3 crore in FY24. In February 2026, the company announced a strategic realignment to run down its intermediated lower-yield portfolio. - After five years with no subsidiaries, UGRO added three entities via two acquisitions and immediately initiated a merger
Minor- From FY2020 through FY2025, UGRO Capital had no subsidiaries. On 8 December 2025, it acquired 100% of Profectus Capital Private Limited for ₹1,398.6 crore in cash, and on 18 March 2026 it acquired Datasigns Technologies Private Limited for ₹38.23 crore, bringing in a step-down subsidiary the same day. The Board approved a Scheme of Amalgamation to merge Profectus Capital into UGRO on 8 January 2026, with an appointed date of 1 April 2026. - Only minor, procedural fines from stock exchanges have been received, with no material regulatory actions
Clean- BSE and NSE imposed fines ranging from ₹11,800 to ₹99,120 across FY2022-23 to FY2024-25 for disclosure delays and procedural non-compliance under SEBI LODR Regulations. No penalties were imposed by RBI or other regulators during FY2025-26, FY2022-23, FY2021-22, or FY2019-20. RBI provided a No Objection Certificate for the Profectus Capital merger. - Operating cash flow has turned positive and now covers PAT, with management stating capital is self-generated
Clean- In FY26, cash flow from operations was ₹214 crore against a profit after tax of ₹175 crore, a coverage ratio of 1.22x. The company raised ₹915 crore of equity capital in FY26 through preferential allotment of CCDs and a rights issue, and management stated in Q4 FY26 that the company is “now generating capital, not consuming it”. No dividend was recommended for FY2025-26.
What to watch
- SEBI disclosure requirement. SEBI’s 10 July 2026 comments on the Profectus merger scheme require disclosure of all ongoing adjudication, recovery, prosecution, and enforcement actions against the company, its promoters, and directors.
- Merger approvals. The Scheme of Amalgamation with Profectus Capital Private Limited, filed with NCLT Mumbai Bench on 17 July 2026, awaits NCLT, SEBI, and RBI approvals.
- MD remuneration resolution. The variable compensation resolution that failed at the 29 May 2026 AGM may be re-presented to shareholders during Mr. Nath’s five-year term running to 21 June 2031.
- Fifth auditor’s first year. Completion of G.P. Kapadia & Co.’s first-year audit for FY2026-27.
- Audit trail limitation. Whether the auditor obtains independent assurance for the third-party software systems for which the audit trail could not be commented upon in the FY26 audit.
Bottom line: This is a disclosed and audited record with cash flow that now covers profit and a clean regulatory history. The risk sits in three places: the promoter MD’s compensation structure, which embeds guaranteed payouts against near-zero promoter equity; the appointment of a new auditor for FY2026-27, which introduces continuity risk; and the growing off-book loan book alongside rising on-book debt. Read the remuneration disclosures and the new auditor’s first report with those in mind, and watch whether the Profectus merger clears its pending approvals.